Secondary myelodysplasia with monosomy 7 arising after treatment for acute lymphoblastic leukemia in childhood

V. M. Aquino, N. R. Schneider, E. S. Sandler

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Monosomy 7 is recognized as a characteristic, clonal abnormality associated with acquired myelodysplasia (MDS) or acute myeloid leukemia (AML). It can occur as a late complication of cytotoxic therapy and is usually associated with exposure to alkylating agents or radiation therapy. We report two patients with therapy-related myelodysplasia (t-MDS) associated with monosomy 7 occurring in children after completion of therapy for acute lymphoblastic leukemia (ALL). Both children were noted to have t-MDS with monosomy 7 at the time of cessation of chemotherapy. Neither child had received an alkylating agent or radiation therapy during treatment. One child had a unique dicentric marker chromosome that was shown by fluorescent in situ hybridization to be derived from chromosome 7. This report emphasizes the need to identify and minimize therapy-related side effects without compromising cure rates.

Original languageEnglish (US)
Pages (from-to)48-50
Number of pages3
JournalJournal of Pediatric Hematology/Oncology
Volume23
Issue number1
DOIs
StatePublished - 2001

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Alkylating Agents
Radiotherapy
Therapeutics
Chromosomes, Human, Pair 7
Fluorescence In Situ Hybridization
Genetic Markers
Acute Myeloid Leukemia
Monosomy Chromosome 7
Drug Therapy

Keywords

  • Leukemia
  • Monosomy 7
  • Myelodysplasia
  • Pediatrics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this

Secondary myelodysplasia with monosomy 7 arising after treatment for acute lymphoblastic leukemia in childhood. / Aquino, V. M.; Schneider, N. R.; Sandler, E. S.

In: Journal of Pediatric Hematology/Oncology, Vol. 23, No. 1, 2001, p. 48-50.

Research output: Contribution to journalArticle

@article{2e197d0f508947fe902248cd88c9b118,
title = "Secondary myelodysplasia with monosomy 7 arising after treatment for acute lymphoblastic leukemia in childhood",
abstract = "Monosomy 7 is recognized as a characteristic, clonal abnormality associated with acquired myelodysplasia (MDS) or acute myeloid leukemia (AML). It can occur as a late complication of cytotoxic therapy and is usually associated with exposure to alkylating agents or radiation therapy. We report two patients with therapy-related myelodysplasia (t-MDS) associated with monosomy 7 occurring in children after completion of therapy for acute lymphoblastic leukemia (ALL). Both children were noted to have t-MDS with monosomy 7 at the time of cessation of chemotherapy. Neither child had received an alkylating agent or radiation therapy during treatment. One child had a unique dicentric marker chromosome that was shown by fluorescent in situ hybridization to be derived from chromosome 7. This report emphasizes the need to identify and minimize therapy-related side effects without compromising cure rates.",
keywords = "Leukemia, Monosomy 7, Myelodysplasia, Pediatrics",
author = "Aquino, {V. M.} and Schneider, {N. R.} and Sandler, {E. S.}",
year = "2001",
doi = "10.1097/00043426-200101000-00011",
language = "English (US)",
volume = "23",
pages = "48--50",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Secondary myelodysplasia with monosomy 7 arising after treatment for acute lymphoblastic leukemia in childhood

AU - Aquino, V. M.

AU - Schneider, N. R.

AU - Sandler, E. S.

PY - 2001

Y1 - 2001

N2 - Monosomy 7 is recognized as a characteristic, clonal abnormality associated with acquired myelodysplasia (MDS) or acute myeloid leukemia (AML). It can occur as a late complication of cytotoxic therapy and is usually associated with exposure to alkylating agents or radiation therapy. We report two patients with therapy-related myelodysplasia (t-MDS) associated with monosomy 7 occurring in children after completion of therapy for acute lymphoblastic leukemia (ALL). Both children were noted to have t-MDS with monosomy 7 at the time of cessation of chemotherapy. Neither child had received an alkylating agent or radiation therapy during treatment. One child had a unique dicentric marker chromosome that was shown by fluorescent in situ hybridization to be derived from chromosome 7. This report emphasizes the need to identify and minimize therapy-related side effects without compromising cure rates.

AB - Monosomy 7 is recognized as a characteristic, clonal abnormality associated with acquired myelodysplasia (MDS) or acute myeloid leukemia (AML). It can occur as a late complication of cytotoxic therapy and is usually associated with exposure to alkylating agents or radiation therapy. We report two patients with therapy-related myelodysplasia (t-MDS) associated with monosomy 7 occurring in children after completion of therapy for acute lymphoblastic leukemia (ALL). Both children were noted to have t-MDS with monosomy 7 at the time of cessation of chemotherapy. Neither child had received an alkylating agent or radiation therapy during treatment. One child had a unique dicentric marker chromosome that was shown by fluorescent in situ hybridization to be derived from chromosome 7. This report emphasizes the need to identify and minimize therapy-related side effects without compromising cure rates.

KW - Leukemia

KW - Monosomy 7

KW - Myelodysplasia

KW - Pediatrics

UR - http://www.scopus.com/inward/record.url?scp=0035147190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035147190&partnerID=8YFLogxK

U2 - 10.1097/00043426-200101000-00011

DO - 10.1097/00043426-200101000-00011

M3 - Article

VL - 23

SP - 48

EP - 50

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 1

ER -